|
|
| (22 intermediate revisions not shown.) |
| Line 1: |
Line 1: |
| - | <StructureSection load='1g5m' size='400' side='right' scene='' caption='NMR structure of bcl-2 [[1g5m]]'> | + | <StructureSection load='1g5m' size='350' side='right' scene='' caption='NMR structure of bcl-2 [[1g5m]]'> |
| - | [[Image:Bcl-2_3D.jpg|left|200px]] [[Bcl-2]] family are pro-survival proteins. The name is derived from B-cell lymphoma 2. | + | [[Image:Bcl-2_3D.jpg|left|200px]] |
| - | '''Bcl-xL''' known as survival protein is the regulator of apoptosis. '''Mcl-1''' is an induced myeloid cell leukemia differentiation protein. '''Bcl-2-L-7''' is called '''Bak''' for Bcl-2 homologous antagonist/killer. | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | '''B-cell lymphoma proteins''' (Bcl) family are pro-survival proteins or '''apoptosis regulators'''. |
| | + | *'''Bcl-2''' and '''Bcl-xL''' suppress cell death. |
| | + | *'''Bak''' or '''Bcl-2-like-7''' or '''Bcl-2 homologous antagonist/killer''' and '''Bax''' or '''Bcl-2-like-4''' promote apoptosis |
| | + | *.'''Bcl-xL''' (Bcl-2-like protein 1) known as '''survival protein''' is the regulator of apoptosis. |
| | + | *'''Mcl-1''' is an '''induced myeloid cell leukemia differentiation protein'''. |
| | + | *'''Bcl-2-like-11''' is called '''Bim'''. |
| | + | '''BH3 domain''' is a Bcl-2 homology 3 domain present in Bcl-2 protein family. |
| | + | |
| | + | For '''Bcl-6''' see also [[BCL6 (Hebrew)]] |
| | | | |
| | {{Clear}} | | {{Clear}} |
| Line 31: |
Line 56: |
| | [[Image:signal transduction.jpg|left|500px]] | | [[Image:signal transduction.jpg|left|500px]] |
| | {{Clear}} | | {{Clear}} |
| - | </StructureSection> | |
| - | ==3D structures of Bcl-2== | |
| | | | |
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
| + | ==3D structures of B-cell lymphoma proteins== |
| - | {{#tree:id=OrganizedByTopic|openlevels=0|
| + | [[B-cell lymphoma proteins 3D structures]] |
| | | | |
| - | *Bcl-xL
| + | </StructureSection> |
| - | | + | |
| - | **[[1maz]], [[1r2d]], [[2b48]] – hBcl-xL – human<br />
| + | |
| - | **[[1r2e]], [[1r2g]], [[1r2h]], [[1r2i]], [[3cva]] - hBcl-xL (mutant)<br />
| + | |
| - | **[[1lxl]] - hBcl-xL residues 1-209 - NMR<br />
| + | |
| - | **[[3pl7]] - hBcl-xL (mutant) + apoptosis regulator BAX BH3 domain<br />
| + | |
| - | **[[3fdl]] - hBcl-xL + BH3 peptide<br />
| + | |
| - | **[[3fdm]] - hBcl-xL + α/β peptide foldamer<br />
| + | |
| - | **[[3inq]] - hBcl-xL (mutant) + inhibitor<br />
| + | |
| - | **[[1ysg]] - hBcl-xL + inhibitor<br />
| + | |
| - | **[[2w3l]] – hBcl-xL + quinoline derivative<br />
| + | |
| - | **[[2o1y]], [[2o2m]], [[2o2n]], [[1ysi]], [[1ysn]] - hBcl-xL + sulfonamide derivative – NMR<br />
| + | |
| - | **[[3qkd]] - hBcl-xL + sulfonamide derivative<br />
| + | |
| - | **[[2yxj]] - hBcl-xL + antagonist<br />
| + | |
| - | **[[2pon]] - hBcl-xL + Beclin-1<br />
| + | |
| - | **[[2p1l]] - hBcl-xL (mutant) + Beclin-1<br />
| + | |
| - | **[[1g5j]] - hBcl-xL residues 1-209 + BAD peptide (mutant)<br />
| + | |
| - | **[[3ihc]], [[3iih]], [[1pq0]] – mBcl-xL residues 1-196 – mouse<br />
| + | |
| - | **[[3ihd]], [[3ihe]], [[3ihf]], [[3iig]], [[3ilb]], [[3ilc]] - mBcl-xL residues 1-196 (mutant)<br />
| + | |
| - | **[[2bzw]] - mBcl-xL residues 1-211 + BAD<br />
| + | |
| - | **[[1pq1]] - mBcl-xL residues 1-196 + Bcl-2-like protein 11<br />
| + | |
| - | **[[1af3]] - rBcl-xL soluble domain<br />
| + | |
| - | **[[1bxl]] - Bcl-xL + Bak peptide – ''Escherichia coli'' – NMR<br />
| + | |
| - | | + | |
| - | *Bcl-2
| + | |
| - | | + | |
| - | **[[1gjh]], [[1g5m]] – hBcl-2<br />
| + | |
| - | **[[4aq3]], [[4man]] – hBcl-2 + inhibitor<br />
| + | |
| - | **[[4lvt]], [[4lxd]] – hBcl-2 (mutant) + inhibitor<br />
| + | |
| - | **[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator BAX BH3 domain<br />
| + | |
| - | **[[2o21]], [[2o22]], [[2o2f]], [[1ysw]] - hBcl-2 + sulfonamide derivative - NMR<br />
| + | |
| - | **[[2kua]] – mBcl-2-L-10<br />
| + | |
| - | **[[3io8]] - hBcl-2-L-1 + hBcl-2-L-11 BH3 peptide (mutant)<br />
| + | |
| - | **[[3i1h]] - hBcl-2-L-5 + hBcl-2-L-7<br />
| + | |
| - | **[[2yv6]], [[2imt]], [[2jcn]], [[2ims]] – hBcl-2-L-7<br />
| + | |
| - | **[[3qbr]] - hBcl-2-L-7 + sjA<br />
| + | |
| - | **[[2xpx]] - hBcl-2-L-7 fragment + BHRF1<br />
| + | |
| - | **[[2vm6]] – hBcl-2A1 residues 1-149 + hBcl-2-L-11 peptide<br />
| + | |
| - | **[[2nl9]] – hBcl-2-L-11 + Mcl-1<br />
| + | |
| - | | + | |
| - | *Bcl-w
| + | |
| - | | + | |
| - | **[[1o0l]], [[1mk3]] – hBcl-w (mutant)<br />
| + | |
| - | **[[1zy3]] - hBcl-w (mutant) + BH3 peptide<br />
| + | |
| - | | + | |
| - | *Mcl-1
| + | |
| - | | + | |
| - | **[[2nla]] – rMcl-1 fragment + NoxaB BH3<br />
| + | |
| - | **[[1wsx]] – mMcl-1 residues 152-308<br />
| + | |
| - | **[[2jm6]], [[2rod]] – mMcl-1 fragment + NoxaB fragment – NMR<br />
| + | |
| - | **[[2roc]] - mMcl-1 fragment + Puma<br />
| + | |
| - | **[[3kz0]] - hMcl-1 + peptide MB7<br />
| + | |
| - | **[[3mk8]] - hMcl-1 fragment<br />
| + | |
| - | **[[2mhs]] - hMcl-1 fragment (mutant)<br />
| + | |
| - | **[[3pk1]] – hMcl-1 fragment + hBcl-2-L-4 BH3 domain<br />
| + | |
| - | **[[3kj0]], [[3kj1]], [[3kj2]], [[3io9]] - hMcl-1 fragment + hBcl-2-L-11 BH3 domain (mutant)<br />
| + | |
| - | **[[3d7v]], [[2pqk]] - hMcl-1 fragment + hBcl-2-L-11 BIM BH3<br />
| + | |
| - | **[[2kbw]] - hMcl-1 fragment + BID BH3 peptide – NMR<br />
| + | |
| - | **[[3wix]], [[3wiy]], [[4oq5]], 4oq6]] - hMcl-1 fragment + inhibitor<br />
| + | |
| - | **[[4bpj]] - hMcl-1 fragment + BH3 peptide <br />
| + | |
| - | | + | |
| - | *M11
| + | |
| - | | + | |
| - | **[[2o42]], [[2jbx]] – MvM11L – Myxoma virus<br />
| + | |
| - | **[[2jby]] – MvM11L + Bcl-2 homologous antagonis <br />
| + | |
| - | **[[3dvu]], [[3bl2]] – M11 + Beclin-1 – Murid herpesvirus<br />
| + | |
| - | | + | |
| - | *N1L
| + | |
| | | | |
| - | **[[2i39]] – VvN1L – Vaccinia virus<br /> | |
| - | **[[4bbb]], [[4bbc]], [[4bbd]] – VvN1L (mutant)<br /> | |
| - | }} | |
| | ==References== | | ==References== |
| | | | |